Sigilon Therapeutics' Series A Round

Sigilon Therapeutics raised a round of funding on June 21, 2017. Investors include Flagship Pioneering.

Sigilon Therapeutics discovers and develops category-defining biocompatible encapsulated cell therapies. Sigilon Therapeutics' discovery platform combines cell engineering and biocompatible Afibromer …

Articles about Sigilon Therapeutics' Series A Round: